FDA全球物质注册数据库(FDA Global Substance Registration System)
物质名称DACLATASVIR
异名/同义词BMS 790052
BMS-790052
CARBAMIC ACID, N,N'-((1,1'-BIPHENYL)-4,4'-DIYLBIS(1H-IMIDAZOLE-5,2-DIYL-(2S)-2,1-PYRROLIDINEDIYL((1S)-1-(1-METHYLETHYL)-2-OXO-2,1-ETHANEDIYL)))BIS-, C,C'-DIMETHYL ESTER
DACLATASVIR
DACLATASVIR [INN]
DACLATASVIR [MI]
DACLATASVIR [USAN]
DACLATASVIR [WHO-DD]
DCV
DIMETHYL N,N'-((1,1'-BIPHENYL)-4,4'-DIYLBIS(1H-IMIDAZOLE-5,2-DIYL-((2S)-PYRROLIDINE-2,1-DIYL)((1S)-3-METHYL-1-OXOBUTANE-1,2-DIYL)))DICARBAMATE
EBP 883
EBP-883
CAS登记号1009119-64-5
物质唯一标识(Unique Ingredient Identifier)LI2427F9CI
分子式C40H50N8O6
国际化合物标识(International Chemical Identifier,InChI)FKRSSPOQAMALKA-CUPIEXAXSA-N
SMILESC(N[C@@H](C(C)C)C(N1[C@H](c2[nH]c(-c3ccc(-c4ccc(-c5cnc([C@@H]6CCCN6C([C@@H](NC(OC)=O)C(C)C)=O)[nH]5)cc4)cc3)cn2)CCC1)=O)(OC)=O
分子结构式
欧洲化学品管理局注册号(ECHA)
成分类型INGREDIENT SUBSTANCE / chemical
关联数据
  • 药品国际非专利名称数据库
  • 世界卫生组织药物词典
扩展资源
©2006-2024 Drugfuture->FDA Global Substance Registration System